CBDYNE · Ingredient development · Research

Building better foundations for ingredient innovation.

CBDYNE works across CBD wholesale, ingredient sourcing, private-label manufacturing, testing and consulting services, and laboratory research—bringing a quality-minded, evidence-led approach to an evolving field.

Business-to-businessWholesale and private-label partners, not a consumer storefront.
California · Nevada · ArizonaTerritories we serve.
Hemp sourcing in ColombiaHemp cultivation and sourcing activity.

Research with care

Ambition, grounded in evidence.

We are developing a kratom-related investigational program, with human clinical trials targeted to begin in Q2 2027. A separate CBD research program is also under development.

Q2 2027
Target start of human clinical trials for our kratom program

Starting human clinical trials is a research milestone under FDA’s Investigational New Drug (IND) process—not FDA approval, proof of safety or efficacy, or authorization to market a treatment. See our research page for important qualifications.

Partnerships

Let’s build a responsible supply relationship.

For wholesale, private-label and research-related inquiries, contact the team using our inquiry form.

Contact CBDYNE

Our operating focus

Our wholesale and private-label activities serve business partners in California, Nevada and Arizona, with hemp cultivation and sourcing activity in Colombia. Contact us for current availability, specifications and supporting documentation.

Availability, specifications and documentation are confirmed case by case.